EVOLUTIONARY TREE CAPITAL MANAGEMENT, LLC Revance Therapeutics, Inc. Transaction History

EVOLUTIONARY TREE CAPITAL MANAGEMENT, LLC portfolio value:

$5.18M
portfolio value

EVOLUTIONARY TREE CAPITAL MANAGEMENT, LLC quarter portfolio value change:

+95.37%
quarter

Revance Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +42.98% 57.68K shares 3.32M $27 191.86K
Q2 2022 share Decrease -23.90% -42.14K shares -1.58M $13.82 134.18K
Q1 2022 share Decrease -29.05% -72.19K shares -617K $19.5 176.33K
Q4 2021 share Increase +48.65% 81.34K shares -602K $16.49 248.53K
Q3 2021 share Increase +8.06% 12.47K shares 72K $27.86 167.19K
Q2 2021 share Increase +3.13% 4.70K shares 393K $29.64 154.71K
Q1 2021 share Increase +67.90% 60.66K shares 1.66M $27.95 150.01K
Q4 2020 share Increase 0.00% 89.34K shares 2.53M $28.34 89.34K